Partial clinical hold on ADC sinks Mersana shares

Mersana Therapeutics Inc. (NASDAQ:MRSN) lost $5.20 (32%) to $11.26 on Thursday after it said FDA placed a partial clinical hold

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE